| 1 |
34445495 | Gain-of-Function Mutant TP53 R248Q Overexpressed in Epithelial Ovarian Carcinoma Alters AKT-Dependent Regulation of Intercellular Trafficking in Responses to EGFR/MDM2 Inhibitor. | 2021 Aug 16 |
1 |
| 2 |
23820125 | The novel anticancer agent JNJ-26854165 induces cell death through inhibition of cholesterol transport and degradation of ABCA1. | 2013 Sep |
1 |
| 3 |
24040331 | Serdemetan antagonizes the Mdm2-HIF1α axis leading to decreased levels of glycolytic enzymes. | 2013 |
2 |
| 4 |
21831953 | A phase I first-in-human pharmacokinetic and pharmacodynamic study of serdemetan in patients with advanced solid tumors. | 2011 Oct 1 |
3 |
| 5 |
21937165 | Preclinical assessment of JNJ-26854165 (Serdemetan), a novel tryptamine compound with radiosensitizing activity in vitro and in tumor xenografts. | 2011 Dec 22 |
3 |